Editorship

First Editor, Current Topics in Behavioral Neurosciences, Springer 2015

 

Research Articles

Lee, G., Mizgalewicz, A., Borgelt, E., and Illes, J. Genetic Testing and Neuroimaging for Youth at Risk for Mental Illness: Trading off Benefit and Risk. Current Topics in Behavioral Neurosciences, 2014 Jul 24. [Epub ahead of print] 

Zwieger, P., Lee, G., and Shaw, C.A. Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents. Journal of Negative Results in BioMedicine, 2014; 13(1): 14.

Garnett, A., Lee, G., and Illes, J. (2013) Publication trends in neuroimaging of minimally conscious states. PeerJ 1:e155; DOI 10.7717/peerj.155

Lee, G., and Illes, J.  Never say never: Limitations of neuroimaging for communicating decisions after brain injuryAJOB Neuroscience, 2013; 4(1): 58.

Lee, G. and Mizgalewicz, A.  Communication with vegetative state patients: Dialogue or soliloquy?  Neuroethics at the Core, The Blog of the National Core for Neuroethics.

Lee, G., and Shaw, C.A.  Early exposure to environmental toxin contributes to neuronal vulnerability and axonal pathology in familial ALS.  Neuroscience and Medicine, 2012; 3(4): 404–417.

Lee, G., and Shaw, C.A. Disease progression with early toxin-induced neuropathology in the ageing mutant SOD1 mouse model of Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis. 2011; 12(Supp 1): 157–158.

Zwiegers, P., Lee, G., Liu, H-N, Robertson, J., and Shaw, C.A. Do neurotoxic insults cause misfolding of SOD1 in an animal model of sporadic ALS?  Amyotrophic Lateral Sclerosis. 2010; 11(Suppl 1): 76.

Lee, G., Chu, T., and Shaw, C.A.  The primary locus of motor neuron death in an ALS-PDC mouse model.  NeuroReport.  2009; 20(14): 1284–1289.

Lee, G.  The interaction of environmental and genetic factors in ALS. The Northern Neuron.  2007; 3.1: 22.

Fazakerley, J.K., Cotterill, C.L., Lee, G., and Graham, A. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest Virus infected mouse brain: a novel system to study virus oligodendrocyte interactionsNeuropathology and Applied Neurobiology. 2006; 32(4): 397-409.

Conference Proceedings

Lee, G., Byram, A.C., Stables, C., Mizgalewicz, A., Ribary, U., Owen, A.M., and Illes, J. A framework for assessing the clinical actionability of functional neuroimaging for disorders of consciousness. AJOB Neuroscience 2012

Lee, G., and Shaw, C.A. Disease progression with early toxin-induced neuropathology in the ageing mutant SOD1 mouse model of Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis. 2011; 12(Supp 1): 157–158.

Zwiegers, P., Lee, G., Liu, H-N, Robertson, J., and Shaw, C.A. Do neurotoxic insults cause misfolding of SOD1 in an animal model of sporadic ALS?  Amyotrophic Lateral Sclerosis. 2010; 11(Suppl 1): 76.

 

Contributions to Blogs

Lee, G. and Mizgalewicz, A.  Communication with vegetative state patients: Dialogue or soliloquy?  Neuroethics at the Core, The Blog of the National Core for Neuroethics.

 

Dissertation

Kam, Grace Lee  (2011) Determination of disease progression with early toxin-induced neuropathology in the ageing mutant SOD mouse model of amyotrophic lateral sclerosis.

 

Abstracts

Lee, G., Byram, A., Stables, C., Mizgalewicz, A., Ribary, U., Owen, A.M., & Illes, J.  A framework for assessing the clinical actionability of functional neuroimaging for disorders of consciousness.  2012 International Neuroethics Society Annual Meeting, October 2012, New Orleans, Louisiana, USA.

Lee, G., & Shaw, C.A.  Disease progression with early toxin-induced neuropathology in the ageing mutant SOD1 mouse model of ALS.  22nd International Symposium on ALS/MND, December 2011, Sydney, Australia.

Lee, G., & Shaw, C.A.  Determination of disease progression with early toxin-induced neuropathology in the ageing mutant SOD mouse model of amyotrophic lateral sclerosis.  Canadian Student Health Research Forum, June 2011, Winnipeg, MB.

Lee, G., & Shaw, C.A.  Determination and progression of toxin-induced neuropathology in the ageing mutant SOD1 mouse central nervous system.  21st International Symposium on ALS/MND, December 2010, Orlando, Florida, USA.

Lee, G., Hilton, B.J., & Shaw, C.A.  Exposure to steryl glucosides in vivo contributes to disease progression in the mSODG37R line 29 mouse model of amyotrophic lateral sclerosis.  20th International Symposium on ALS/MND, December 2009, Berlin, Germany.

Lee, G., Sommerfeld, D.D., & Shaw, C.A.  Juvenile-onset amyotrophic lateral sclerosis (ALS2) and the effect of dietary sterol glucosides:  an analysis of the interaction between genes and environment.  Society for Neuroscience, October 2009, Chicago, IL.

Lee, G., Sommerfeld, D.D., Hilton, B.J., & Shaw, C.A.  Interplay of genes and early exposure to dietary sterols:  Bridging the gap between genetic and environmental models of ALS.  Fifth Annual ALS Canada meeting, May 2009, Toronto, ON.

Lee, G., Orban, P.C., Hayden, M.R., & Shaw, C.A.  Interaction of Als2 gene deficiency with dietary neurotoxin leads to increased pathophysiological features. Society for Neuroscience, November 2008, Washington, DC.

Lee, G., Orban, P.C., Hayden, M.R., & Shaw, C.A.  Pathophysiological features with Als2 gene deficiency and dietary neurotoxins.   Fourth Annual ALS Canada meeting, May 2008, Toronto, ON.

Shaw, C.A., Tabata, R., Lee, G., Cruz-Aguado, R., & Ly, P.T.T. Timelines of behavioural, anatomical, and biochemical changes in the CNS of an animal model of ALS-PDC of Guam. 18th International Symposium on ALS/MND, July 2007.

Lee, G., Cruz-Aguado R., Banjo, O.C., & Shaw, C.A. Characterization of gait analysis, memory, and neuromuscular junction integrity in a mouse model of ALS-PDC. Society for Neuroscience, November 2007, San Diego, CA.

Lee, G., Cruz-Aguado, R., Orban, P.C., McCue, S., Hampton, T., Hayden, M.R., & Shaw, C.A. Do cycad neurotoxins amplify the genetic defect caused by the ALS2 mutations:  Characterization of axonopathy in a mouse model of ALS-Parkinsonism Dementia Complex.  Third Annual ALS Canada Meeting, March 2007, Toronto, ON.

Lee, G., Cruz-Aguado, R., Orban, P.C., McCue, S., Hampton, T., Hayden, M.R., & Shaw, C.A. Neurotoxic susceptibility in a mouse model of ALS2 as revealed by behavioral analysis.  Society for Neuroscience Abstracts, November 2006, Atlanta, GA.